Ocugen, Inc.
OCGN
$0.698
-$0.0045-0.64%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.48M | 764.00K | 1.14M | 1.14M | 1.01M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.48M | 764.00K | 1.14M | 1.14M | 1.01M |
| Cost of Revenue | 786.00K | 8.29M | 8.11M | 8.90M | 445.00K |
| Gross Profit | 695.00K | -7.53M | -6.97M | -7.76M | 569.00K |
| SG&A Expenses | 6.45M | 6.31M | 6.28M | 7.69M | 6.40M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.98M | 14.60M | 14.39M | 16.59M | 13.23M |
| Operating Income | -14.50M | -13.84M | -13.25M | -15.45M | -12.22M |
| Income Before Tax | -15.35M | -13.88M | -12.97M | -15.28M | -11.92M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -15.35M | -13.88M | -12.97M | -15.28M | -11.92M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -15.35M | -13.88M | -12.97M | -15.28M | -11.92M |
| EBIT | -14.50M | -13.84M | -13.25M | -15.45M | -12.22M |
| EBITDA | -13.59M | -13.24M | -12.64M | -14.87M | -12.04M |
| EPS Basic | -0.05 | -0.05 | -0.05 | -0.06 | -0.05 |
| Normalized Basic EPS | -0.03 | -0.03 | -0.03 | -0.04 | -0.03 |
| EPS Diluted | -0.05 | -0.05 | -0.05 | -0.06 | -0.05 |
| Normalized Diluted EPS | -0.03 | -0.03 | -0.03 | -0.04 | -0.03 |
| Average Basic Shares Outstanding | 292.00M | 290.92M | 278.17M | 257.51M | 257.23M |
| Average Diluted Shares Outstanding | 292.00M | 290.92M | 278.17M | 257.51M | 257.23M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |